This study demonstrates the efficacy of dendritic cell‐mediated anticancer immunotherapy in allograft melanoma models and metastatic breast cancer models by producing major histocompatibility complex (MHC) I binding peptide epitopes of survivin proteins expressed in various cancers in the form of self‐assembled nanostructures with dual adjuvants. This evidence concerns the gene BIRC5 and melanoma.